Skip to content

Pragmatic Randomised Controlled Trial Evaluating Effectiveness of a Smoking Cessation e- Intervention Tabac Info Service

Evaluation of Effectiveness of Tabac Info Service (EE-TIS)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02841683
Enrollment
2806
Registered
2016-07-22
Start date
2017-09-01
Completion date
2019-09-01
Last updated
2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Smoking

Brief summary

Introduction - A national smoking cessation E-intervention, called Tabac Info Service (TIS), was developed in France to provide an adapted web and mobile application support to smoking cessation for all adults smokers, with or without chronic diseases, who want to stop smoking. This paper presents the study protocol of the evaluation of the program. The primary objective of this evaluation is to assess the efficacy and efficacy conditions of eTIS. The secondary objectives are to 1) describe efficacy variations in regard to user characteristics, 2) analyze mechanisms and efficacy conditions of eTIS, through variations of use, social or environmental contextual factors likely to influence the efficacy of eTIS, and the behavior change techniques (BCTs). Methods and analyses - The study design is a two-arm pragmatic randomized controlled trial including a process evaluation with at least 3000 participants randomized to the intervention or to the control arm (current practices presented in a non-interactive website). Inclusion criteria are: Adults, Smokers with an information and consent form completed, Getting a smartphone and using mobile applications, wanting stop to smoking in short, medium or long terms. The exclusion criterion is the refusal to participate in the study. The primary outcome is the point prevalence abstinence of 7 days at 6 months later. The secondary outcomes are: the point prevalence abstinence of 24 h at 3 months later, the point prevalence abstinence of 30 days at 12 months later, number of quit attempts during the study, progression of stages within the program (changes and duration in each stage). Data will be analyzed in Intention to treat (main analyze) and per protocol ways. A logistic regression will be carried out to estimate an OR \[95% confidence interval\] for efficacy. A multivariate multilevel analysis will explore the influence of patients' characteristics, social and environmental context, conditions of use and behavior change techniques on results. Dissemination -The findings of this study will allow us to understand and characterize the efficacy of eTIS, and conditions of its efficacy, underlining psychological, sociological, environmental and contextual factors, which could influence the efficacy of this type of intervention on smokers. These findings will be disseminated through peer-reviewed journals, national and international conference presentations and public events.

Interventions

BEHAVIORALTabac Info Service

A smoking cessation E-intervention, Tabac Info Service (TIS), by website and mobile application

Sponsors

Ecole des Hautes Etudes en Santé Publique
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adult smokers * with an information and consent form completed * agreed to participate in the study * get a Smartphone and be willing to use applications * wanting stop smoking (in short, medium or long terms).

Exclusion criteria

* refusal to participate in the study

Design outcomes

Primary

MeasureTime frame
Point prevalence abstinence of 7 days6 months

Secondary

MeasureTime frameDescription
continuous abstinence rate6 monthsDefined as the proportion of participants remaining continuously abstinent from the cessation date to the endpoint
minimum 24-hour point abstinence3 months
minimum 30-day point abstinence12 months
number of quit attempts6 months
total duration of quit attempts6 monthscalculated as sum of days with no use

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026